ARCHIVES

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

USLA’’s Steckel Asks More Centers Staff, Strict Enforcement of Guidelines

February 17, 1978

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000